Short group psychoeducation followed by daily electronic self-monitoring in the long-term treatment of bipolar disorders: a multicenter, rater-blind, randomized controlled trial.

Bipolar disorder Psychotherapy Quality of life Recurrence Self efficacy Self report Self-management

Journal

International journal of bipolar disorders
ISSN: 2194-7511
Titre abrégé: Int J Bipolar Disord
Pays: Germany
ID NLM: 101622983

Informations de publication

Date de publication:
04 Nov 2019
Historique:
received: 24 05 2019
accepted: 20 08 2019
entrez: 5 11 2019
pubmed: 5 11 2019
medline: 5 11 2019
Statut: epublish

Résumé

Despite various pharmacological and psychological treatment interventions, bipolar disorders rank among the leading causes of global disease burden. Group psychoeducation has been demonstrated an effective add-on to pharmacotherapy, but it may be difficult to implement in practice depending on the clinical setting and available human resources. Multicenter, rater-blind, randomized controlled trial to investigate the efficacy of a new intervention program consisting of an initial 6-week psychoeducation protocol plus a subsequent structured daily computer-based self-charting program (ChronoRecord) over 54 weeks in remitted patients with bipolar disorders. The control condition included non-structured group sessions followed by daily computer-based self-reports (unstructured like a diary). Both groups received treatment-as-usual. Over 2 years, 41 mood episodes occurred in the experimental group (n = 39) compared to 27 in the control group (n = 34), without reaching statistical significance. Time to recurrence did not significantly differ between the experimental and control group (25% relapsed after 112 and 273 days, respectively). There were no significant group-by-time interactions in mood symptoms, quality of life, self-efficacy expectations or perceived involvement in care. Six weekly psychoeducational group sessions followed by daily self-monitoring via ChronoRecord for 54 weeks may not be superior to non-structured group meetings followed by unstructured self-reporting. Other psychotherapeutic interventions may be needed to optimize the treatment of patients with bipolar disorders, especially for those at later disease stages. Trial registration Retrospectively registered at German Clinical Trials Register on May 24, 2019; DRKS00017319.

Sections du résumé

BACKGROUND BACKGROUND
Despite various pharmacological and psychological treatment interventions, bipolar disorders rank among the leading causes of global disease burden. Group psychoeducation has been demonstrated an effective add-on to pharmacotherapy, but it may be difficult to implement in practice depending on the clinical setting and available human resources.
METHODS METHODS
Multicenter, rater-blind, randomized controlled trial to investigate the efficacy of a new intervention program consisting of an initial 6-week psychoeducation protocol plus a subsequent structured daily computer-based self-charting program (ChronoRecord) over 54 weeks in remitted patients with bipolar disorders. The control condition included non-structured group sessions followed by daily computer-based self-reports (unstructured like a diary). Both groups received treatment-as-usual.
RESULTS RESULTS
Over 2 years, 41 mood episodes occurred in the experimental group (n = 39) compared to 27 in the control group (n = 34), without reaching statistical significance. Time to recurrence did not significantly differ between the experimental and control group (25% relapsed after 112 and 273 days, respectively). There were no significant group-by-time interactions in mood symptoms, quality of life, self-efficacy expectations or perceived involvement in care.
CONCLUSIONS CONCLUSIONS
Six weekly psychoeducational group sessions followed by daily self-monitoring via ChronoRecord for 54 weeks may not be superior to non-structured group meetings followed by unstructured self-reporting. Other psychotherapeutic interventions may be needed to optimize the treatment of patients with bipolar disorders, especially for those at later disease stages. Trial registration Retrospectively registered at German Clinical Trials Register on May 24, 2019; DRKS00017319.

Identifiants

pubmed: 31680193
doi: 10.1186/s40345-019-0158-8
pii: 10.1186/s40345-019-0158-8
pmc: PMC6826047
doi:

Banques de données

DRKS
['DRKS00017319']

Types de publication

Journal Article

Langues

eng

Pagination

23

Références

Eur Neuropsychopharmacol. 2013 Nov;23(11):1337-9
pubmed: 23643344
Acta Neuropsychiatr. 2010 Apr;22(2):50-3
pubmed: 25385029
Acta Psychiatr Scand. 2014 Sep;130(3):181-92
pubmed: 24697518
Bipolar Disord. 2015 Jun;17(4):349-62
pubmed: 25594775
Psychiatry Res. 2008 Jun 30;159(3):359-66
pubmed: 18423616
Eur Psychiatry. 2010 Oct;25(6):328-33
pubmed: 20444581
J Affect Disord. 2018 Dec 1;241:436-445
pubmed: 30145515
Dtsch Arztebl Int. 2013 Feb;110(6):92-100
pubmed: 23451001
BMC Psychiatry. 2016 Jan 15;16:7
pubmed: 26769120
J Affect Disord. 2016 Sep 01;201:203-14
pubmed: 27243619
Arch Gen Psychiatry. 2003 Apr;60(4):402-7
pubmed: 12695318
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
J Gen Intern Med. 1990 Jan-Feb;5(1):29-33
pubmed: 2299426
Bipolar Disord. 2004 Feb;6(1):67-74
pubmed: 14996143
Lancet Psychiatry. 2016 Nov;3(11):1029-1038
pubmed: 27688021
Br J Psychiatry. 2009 Mar;194(3):260-5
pubmed: 19252157
Arch Gen Psychiatry. 2011 Oct;68(10):1058-64
pubmed: 21969462
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Acta Psychiatr Scand. 2013 Feb;127(2):153-8
pubmed: 22943487
Soc Sci Med. 1995 Nov;41(10):1359-66
pubmed: 8560303
Ann Gen Psychiatry. 2015 Jul 07;14:19
pubmed: 26155299
J Affect Disord. 2009 Jan;112(1-3):30-5
pubmed: 18486237
Psychol Med. 2019 May 6;:1-7
pubmed: 31057138
J Affect Disord. 2017 Nov;222:28-31
pubmed: 28668712
J Clin Psychiatry. 2012 Jun;73(6):803-10
pubmed: 22795205
J Clin Psychiatry. 2003 Sep;64(9):1101-5
pubmed: 14628987
Bipolar Disord. 2019 Feb;21(1):76-85
pubmed: 29578271
J Clin Psychiatry. 2018 May/Jun;79(3):
pubmed: 29727072

Auteurs

Johannes Petzold (J)

Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany. johannes.petzold@uniklinikum-dresden.de.

René Mayer-Pelinski (R)

Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Maximilian Pilhatsch (M)

Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Susan Luthe (S)

Department of Psychiatry, Behavioral and Psychosomatic Medicine, Chemnitz Hospital, Flemmingstr. 2, 09116, Chemnitz, Germany.

Thomas Barth (T)

Department of Psychiatry, Behavioral and Psychosomatic Medicine, Chemnitz Hospital, Flemmingstr. 2, 09116, Chemnitz, Germany.

Michael Bauer (M)

Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Emanuel Severus (E)

Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Classifications MeSH